Quick answerClarify
oteseconazole for any female of reproductive potential.
Why this is correctThis restriction is broader than short-term contraception during dosing. The nurse verifies reproductive-potential status before therapy rather than attempting to create an unlabeled workaround.
Easy analogy or mental pictureBuild a medication-safety chain: identify the changing cue, connect it to the labeled toxicity or interaction, interrupt preventable exposure, stabilize the client, and verify a measurable response.
Memory hookDrug, trend, urgent cue, protective action, and reassessment endpoint.NCLEX decision ruleChoose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.
Why the other choices are wrongOptions that continue a suspect exposure, normalize a labeled danger cue, or delay escalation leave the client at risk.
References
1DailyMed: VIVJOA (oteseconazole)Restriction to females not of reproductive potential and contraindications in reproductive potential, pregnancy, and lactation